Accelerating The Drug Approval Process Life Science Leader Magazine Based on cyclosporine, a compound originally used for the suppression of organ transplant rejection, RESTASIS was able to take advantage of the well-known liver toxicity data in addition to that which Allergan generated. When evaluating RESTASIS for ... |
